Gladstone/UCSF team discovers interaction of two brain proteins may be key factor in development of Alzheimer's disease

A team of San Francisco scientists studying Alzheimer's disease has found the interaction of two brain proteins may be a critical factor in development of the debilitating disorder.

Both proteins have been the focus of intense scientific scrutiny because of their independent roles in different diseases and basic cell biology. The current study reveals a novel interaction between the two that could help explain the death of nerve cells associated with Alzheimer's disease, or AD. Understanding this process could lead to development of better treatments to prevent or slow the degeneration of nerve cells that causes memory loss or disturbed thinking that are symptoms of the illness.

The research, conducted by researchers from the Gladstone Institute of Neurological Disease (GIND) and the University of California San Francisco, is reported in the new issue (June 22) of the Proceedings of the National Academy of Sciences.

One of the proteins, amyloid precursor protein, or APP, is normally found at high levels in the brain, but its function is largely unknown. The second protein is p53, which under certain conditions turns on an internal cell suicide process that leads to the death of the cell. In the case of nerve cells, this process can be devastating to the brain because most of these cells are irreplaceable.

Mutant forms of APP are associated with certain forms of AD, but how they cause the death of brain cells has been a mystery. Now the new research findings provide some clues.

The researchers, led by Gladstone staff research scientist Xiao Xu, MD, PhD, and Lennart Mucke, MD, director of the GIND and associate professor of neurology and neuroscience at UCSF, found that normal APP--known as "wild-type" APP--provides a protective function against nerve cell death, inhibiting the p53-induced suicide process in cell cultures. Findings showed mutant forms of APP do not provide this protection.

AD is a disorder of the central nerv

Contact: Corinna Kaarlela
University of California - San Francisco

Page: 1 2 3 4

Related biology news :

1. New Gladstone/UCSF study finds inhibiting fat synthesis results in obesity resistance in mice
2. LSU researcher discovers new bird
3. MIT team discovers memory mechanism
4. OHSU team discovers compound that lacks estrogens risks
5. SMCM professor discovers cattle hormones that leak into streams and alter fish reproduction
6. UBC researcher discovers control room that regulates immune responses
7. UC Santa Barbara discovers cell survival gene may lead to treatments for degenerative diseases
8. Brain patterns the same whether doing or just watching, Queens researcher discovers
9. Study discovers key to baby-like skin
10. Rutgers researcher discovers melanoma causing gene
11. UI study discovers cells segregate molecules to control signaling

Post Your Comments:

(Date:8/5/2020)... (PRWEB) , ... August 05, 2020 , ... Regenative Labs ... two new innovations, CoreText™ and ProText™, making them the first Wharton’s jelly allografts to ... using a syringe. The company’s solutions are the first Wharton’s jelly allograft product to ...
(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, Inc. today announced a ... Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of ... a highly efficient mammalian cell culture-based bioprocess suitable to meet surge requirement needs ...
(Date:7/22/2020)... ... July 21, 2020 , ... ... and innovation in technology and compliance, announces a new solution to manage regulated ... ensure every layer of their technology stack complies with FDA and global regulations. ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
(Date:7/31/2020)... FRANCISCO (PRWEB) , ... July ... ... provider of cloud-based software for the life sciences industry, today announced the ... presentation platform designed specifically for Medical Science Liaisons (MSLs) and other field ...
(Date:7/18/2020)... ... July 17, 2020 , ... ... for the life sciences and food industries, is pleased to announce that Charles ... Research – Business Development. , Charles is an accomplished and results-driven sales executive ...
(Date:7/7/2020)... (PRWEB) , ... July 06, 2020 , ... R3 International ... program featuring up to 200 million stem cells. Depending on the patient's condition, treatment ... in the US will die having some form of Alzheimers dementia, and the incidence ...
Breaking Biology Technology:
Cached News: